Frits Hm van Osch1, Sylvia Hj Jochems2, Frederik-Jan van Schooten3, Richard T Bryan4, Maurice P Zeegers5. 1. Department of Complex Genetics, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands, Department of Complex Genetics, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands, f.vanosch@maastrichtuniversity.nl. 2. Department of Complex Genetics, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. 3. Department of Pharmacology and Toxicology, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands and. 4. Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. 5. Department of Complex Genetics, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK, Department of Complex Genetics, CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands.
Abstract
BACKGROUND: Smoking is a major risk factor for bladder cancer (BC). This meta-analysis updates previous reviews on smoking characteristics and BC risk, and provides a more quantitative estimation of the dose-response relationship between smoking characteristics and BC risk. METHODS: In total, 89 studies comprising data from 57 145 BC cases were included and summary odds ratios (SORs) were calculated. Dose-response meta-analyses modelled relationships between smoking intensity, duration, pack-years and cessation and BC risk. Sources of heterogeneity were explored and sensitivity analyses were conducted to test the robustness of findings. RESULTS: Current smokers (SOR = 3.14, 95% CI = 2.53-3.75) and former smokers(SOR = 1.83, 95% CI = 1.52-2.14) had an increased risk of BC compared with never smokers. Age at first exposure was negatively associated with BC risk. BC risk increased gradually by smoking duration and a risk plateau at smoking 15 cigarettes a day and 50 pack-years was observed. Smoking cessation is most beneficial from 20 years before diagnosis. The population-attributable risk of BC for smokers has decreased from 50% to 43% in men and from 35% to 26% in women from Europe since estimated in 2000. Results were homogeneous between sources of heterogeneity, except for lower risk estimates found in studies of Asian populations. CONCLUSIONS: Active smokers are at an increased risk of BC. Dose-response meta-analyses showed a BC risk plateau for smoking intensity and indicate that even after long-term smoking cessation, an elevated risk of bladder cancer remains.
BACKGROUND: Smoking is a major risk factor for bladder cancer (BC). This meta-analysis updates previous reviews on smoking characteristics and BC risk, and provides a more quantitative estimation of the dose-response relationship between smoking characteristics and BC risk. METHODS: In total, 89 studies comprising data from 57 145 BC cases were included and summary odds ratios (SORs) were calculated. Dose-response meta-analyses modelled relationships between smoking intensity, duration, pack-years and cessation and BC risk. Sources of heterogeneity were explored and sensitivity analyses were conducted to test the robustness of findings. RESULTS: Current smokers (SOR = 3.14, 95% CI = 2.53-3.75) and former smokers(SOR = 1.83, 95% CI = 1.52-2.14) had an increased risk of BC compared with never smokers. Age at first exposure was negatively associated with BC risk. BC risk increased gradually by smoking duration and a risk plateau at smoking 15 cigarettes a day and 50 pack-years was observed. Smoking cessation is most beneficial from 20 years before diagnosis. The population-attributable risk of BC for smokers has decreased from 50% to 43% in men and from 35% to 26% in women from Europe since estimated in 2000. Results were homogeneous between sources of heterogeneity, except for lower risk estimates found in studies of Asian populations. CONCLUSIONS: Active smokers are at an increased risk of BC. Dose-response meta-analyses showed a BC risk plateau for smoking intensity and indicate that even after long-term smoking cessation, an elevated risk of bladder cancer remains.
Authors: Veronica Sciannameo; Angela Carta; Angelo d'Errico; Maria Teresa Giraudo; Francesca Fasanelli; Cecilia Arici; Milena Maule; Paolo Carnà; Paolo Destefanis; Luigi Rolle; Paolo Gontero; Giovanni Casetta; Andrea Zitella; Giuseppina Cucchiarale; Paolo Vineis; Stefano Porru; Carlotta Sacerdote; Fulvio Ricceri Journal: Int Arch Occup Environ Health Date: 2018-11-30 Impact factor: 3.015
Authors: Xuezheng Sun; Katherine A Hoadley; William Y Kim; Helena Furberg; Andrew F Olshan; Melissa A Troester Journal: Cancer Causes Control Date: 2017-03-20 Impact factor: 2.506
Authors: Merab Acham; Anke Wesselius; Frits H M van Osch; Evan Yi-Wen Yu; Piet A van den Brandt; Emily White; Hans-Olov Adami; Elisabete Weiderpass; Maree Brinkman; Graham G Giles; Roger L Milne; Maurice P Zeegers Journal: Eur J Clin Nutr Date: 2019-06-17 Impact factor: 4.016
Authors: Juliet A Usher-Smith; Stephen J Sharp; Robert Luben; Simon J Griffin Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-09-13 Impact factor: 4.254
Authors: Frits H M van Osch; Jelle Vlaanderen; Sylvia H J Jochems; Cristina Bosetti; Jerry Polesel; Stefano Porru; Angela Carta; Klaus Golka; Xuejuan Jiang; Mariana C Stern; Wei-De Zhong; Eliane Kellen; Hermann Pohlabeln; Li Tang; James Marshall; Gunnar Steineck; Margaret R Karagas; Kenneth C Johnson; Zuo-Feng Zhang; Jack A Taylor; Carlo La Vecchia; Richard T Bryan; Frederik J van Schooten; Anke Wesselius; Maurice P Zeegers Journal: Epidemiology Date: 2019-05 Impact factor: 4.822